You are here
GMP clearance guidance
Version 18.1, January 2019
This guidance is for sponsors seeking to obtain Good Manufacturing Practice (GMP) clearance for an overseas manufacturing site used in the manufacture of a medicine, or an Active Pharmaceutical Ingredient (API) used in a medicine, intended for supply in Australia.
This guidance is not intended for sponsors of:
- biologicals, human blood and blood components and Haematopoietic Progenitor Cells (HPCs), because Australia has its own manufacturing standard for these product types; however, where the manufacturing site performs only sterilisation of these product types, this guidance may be used
- some complementary and listed medicines, including sunscreens, because these may not be regulated as medicines in other countries
Further information is available in the Australian manufacturing licences and overseas GMP certification guidance.